160 related articles for article (PubMed ID: 22445625)
21. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
22. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
[TBL] [Abstract][Full Text] [Related]
23. Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors.
Ikeda K; Yanagihashi M; Sawada M; Hanashiro S; Kawabe K; Iwasaki Y
Intern Med; 2014; 53(9):1007-10. PubMed ID: 24785894
[TBL] [Abstract][Full Text] [Related]
24. Update on Alzheimer drugs (donepezil).
Smith Doody R
Neurologist; 2003 Sep; 9(5):225-9. PubMed ID: 12971832
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
[TBL] [Abstract][Full Text] [Related]
27. [Post-marketing observational study of donepezil].
Ibach B
Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
[No Abstract] [Full Text] [Related]
28. Donepezil: tolerability and safety in Alzheimer's disease.
Pratt RD; Perdomo CA; Surick IW; Ieni JR
Int J Clin Pract; 2002 Nov; 56(9):710-7. PubMed ID: 12469988
[TBL] [Abstract][Full Text] [Related]
29. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
[TBL] [Abstract][Full Text] [Related]
30. Donepezil for severe Alzheimer's disease.
Opie LH
Lancet; 2006 Jul; 368(9533):361-2; author reply 362. PubMed ID: 16876651
[No Abstract] [Full Text] [Related]
31. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
[TBL] [Abstract][Full Text] [Related]
32. [Extra-pyramidal syndrome induced by donepezil].
Carcenac D; Martin-Hunyadi C; Kiesmann M; Demuynck-Roegel C; Alt M; Kuntzmann F
Presse Med; 2000 May; 29(18):992-3. PubMed ID: 10862247
[TBL] [Abstract][Full Text] [Related]
33. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
[TBL] [Abstract][Full Text] [Related]
34. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
Blesa R; Bullock R; He Y; Bergman H; Gambina G; Meyer J; Rapatz G; Nagel J; Lane R
Pharmacogenet Genomics; 2006 Nov; 16(11):771-4. PubMed ID: 17047484
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
[TBL] [Abstract][Full Text] [Related]
36. [Acetylcholinesterase inhibitor. Helpful not just in Alzheimer dementia].
MMW Fortschr Med; 2002 Aug; 144(33-34):59. PubMed ID: 12380156
[No Abstract] [Full Text] [Related]
37. Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in Germany.
Froelich L; Gertz HJ; Heun R; Heuser I; Jendroska K; Kornhuber J; Kurz A; Mueller-Thomsen T; Ries F; Waechtler C; Metz M; Goebel C
Dement Geriatr Cogn Disord; 2004; 18(1):37-43. PubMed ID: 15084792
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic advances: donepezil for the treatment of Alzheimer's disease.
Misson J; Kendall MJ
J Clin Pharm Ther; 1997 Aug; 22(4):251-5. PubMed ID: 9548205
[TBL] [Abstract][Full Text] [Related]
39. Anti-Alzheimer drugs: life-threatening adverse effects.
Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
[TBL] [Abstract][Full Text] [Related]
40. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
